EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease

Ellen Hanna Singleton, Niklas Mattsson-Carlgren, Alexa Pichet Binette, Erik Stomrud, Olof Strandberg, Sebastian Palmqvist, Rik Ossenkoppele, Oskar Hansson

Alzheimer's & Dementia · 2025-07 · 21 (7)

DOI: 10.1002/alz.70435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.07.2025. Verfasst von Ellen Hanna Singleton und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Cognitive Dysfunction, Brain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, GHR Foundation, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The independent contributions of baseline and longitudinal tau positron emission tomography (PET) and magnetic resonance imaging (MRI) to cognitive decline remain unclear. METHODS We included n = 761 amyloid‐positive individuals from the Swedish BioFINDER‐2 study with [ 18 F]RO948‐tau‐PET, 3‐Tesla structural‐MRI, and cognition ( n = 322 with longitudinal imaging data). Linear‐mixed‐models with random‐intercepts and ‐slopes or linear‐regressions were adjusted for age, sex, education, diagnosis, and other‐imaging‐modality. RESULTS Tau‐PET showed stronger associations with cognitive decline than MRI, showing the strongest associations in a neocortical‐composite‐region with a cognitive composite (β = −0.25 ± 0.02, p < 0.001) for baseline and longitudinal tau‐PET (β = −0.62 ± 0.05, p < 0.001). Baseline tau‐PET explained the largest proportion of cognitive decline (54.0%–94.0%), with modest mediation effects for longitudinal tau‐PET or MRI pathways (2.0%–15.0%). Simulated reductions of tau‐PET‐slopes (up to 100%) were associated with marginally altered cognitive trajectories. DISCUSSION The strong associations between baseline tau‐PET and longitudinal cognition, with marginal contributions of longitudinal tau‐PET and MRI, emphasize the importance of baseline tau aggregates for prognostics and treatments in Alzheimer's disease (AD). Highlights Baseline and longitudinal regional tau‐PET uptake were more closely associated than structural MRI with longitudinal cognitive decline. Baseline tau‐PET was a stronger determinant of longitudinal cognitive decline than longitudinal tau‐PET. Simulated reductions of tau‐PET accumulation showed limited alterations of cognitive trajectories, with potential implications for tau‐targeting therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasetau ProteinsCognitive DysfunctionBrainHumansMalePositron-Emission TomographyFemaleMagnetic Resonance ImagingAgedAtrophyLongitudinal StudiesSweden

Stichwörter der Autor:innen

Alzheimer's diseaseMRIclinical trialscognitionlongitudinaltau‐PET

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
  • Memory Clinic, Skåne University Hospital, Malmö, Sweden.
  • Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Förderung

  • European Research Council
  • GHR Foundation
  • Swedish Research Council
  • ERA PerMed
  • Knut and Alice Wallenberg foundation
  • Lund University
  • Swedish Alzheimer Foundation
  • Swedish Brain Foundation

Zitieren

APA

Singleton, E. H., Mattsson-Carlgren, N., Pichet Binette, A., Stomrud, E., Strandberg, O., Palmqvist, S., Ossenkoppele, R., & Hansson, O. (2025). Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease. Alzheimer's & Dementia, 21(7). https://doi.org/10.1002/alz.70435

Vancouver

Singleton EH, Mattsson-Carlgren N, Pichet Binette A, Stomrud E, Strandberg O, Palmqvist S, et al. Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease. Alzheimer's & Dementia. 2025;21(7). doi:10.1002/alz.70435

BibTeX
@article{Singleton2025,
  author = {Singleton, Ellen Hanna and Mattsson-Carlgren, Niklas and Pichet Binette, Alexa and Stomrud, Erik and Strandberg, Olof and Palmqvist, Sebastian and Ossenkoppele, Rik and Hansson, Oskar},
  title = {Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {7},
  doi = {10.1002/alz.70435}
}
Kostenlos starten →